In a rethinking of the organisational structure of the group, Swiss pharmaceutical and agrochemical company Lonza announced on Tuesday that it is to focus on the life sciences sector.The company plans to develop its biotechnology and chemicals capapbilities claiming that growth opportunities are believed to be strong in these chosen markets. In keeping with these plans the group will re-align its management structure to reflect the new objectives.





